Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Millions			12 Months Ended
	Nov. 21, 2023	Sep. 28, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Common Stock [Member]
Loss Contingencies [Line Items]
Number of common stock issued					399,680
Sutro Biopharma Inc [Member]
Loss Contingencies [Line Items]
Number of common stock issued				167,780
Upfront consideration				$ 22.5
Upfront consideration in cash				10.0
Upfront consideration in cash after agreement date				5.0
Option exercise price in cash		$ 25.0		75.0
Additional milestone payments in cash	$ 60.0			60.0
Accrued commitment			$ 25.0
Accrued payment	$ 50.0		$ 50.0	5.0
Fair value on date of settlement				8.0
Sutro Biopharma Inc [Member] | Common Stock [Member]
Loss Contingencies [Line Items]
Upfront consideration				$ 7.5